Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Hånd- og armmotorgendannelse via ikke-invasiv elektrisk rygmarvsstimulering efter slagtilfælde (HARNESS)

30. oktober 2026 opdateret af: Chet Moritz, University of Washington

The recovery from a stroke is often incomplete. It is the leading cause of acquired permanent disability in the adult population. Persistent functional loss of the hand and arm contributes significantly to disability. However, the current standard of care to treat hand and arm movements are inadequate. There is an urgent need for innovative and effective therapies for recovery of the upper limb after stroke.

Growing evidence shows that electrical spinal cord stimulation, combined with activity-dependent rehabilitation, enables voluntary movement of paralyzed muscles in some neurologic disorders, such as spinal cord injury. The investigators hypothesize that spinal networks that lost control after stroke can be activated by non-invasive electrical stimulation of the spinal cord to improve functional recovery.

The aims of the study are:

  1. to determine the improvements in hand and arm function that result from the combined application of non-invasive spinal stimulation and activity-based rehabilitation. Surface electrodes placed over the skin of the neck will be used for non-invasive electrical stimulation of the spinal cord. Functional task practice will be used for activity-dependent rehabilitation,
  2. to evaluate long-lasting benefits to hand and arm function that persist beyond the period of spinal stimulation.

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

6

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

    • Washington
      • Seattle, Washington, Forenede Stater, 98105
        • Rekruttering
        • University of Washington
        • Underforsker:
          • Fatma Inanici, MD, PhD
        • Ledende efterforsker:
          • Chet T Moritz, PhD
        • Kontakt:
          • Fatma Inanici, MD, Ph.D.
          • Telefonnummer: 2067872692
          • E-mail: finanici@uw.edu

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

21 år til 80 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
  • At least six months post-stroke
  • Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
  • Medically and neurologically stable, as determined by medical history and documented physical examination
  • For women of childbearing potential, a negative over-the-counter pregnancy test at study entry and willingness to practice adequate contraception during the study
  • Ability to attend sessions three times per week
  • Adequate social support to participate in all intervention and baseline, follow-up assessment sessions throughout eight months.
  • Ability to read, comprehend and speak English

Exclusion Criteria:

  • Hemorrhagic stroke
  • History of multiple strokes
  • Active implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
  • Aphasia or any other deficit in communication that interferes with reasonable study participation
  • Moderate to severe cognitive impairment
  • Presence of neglect (inability to perceive or awareness of, or loss of attention to the weaker half of the body)
  • Severe spasticity in the upper limb
  • Taking baclofen more than 30 mg/day
  • Change in baclofen dose within four weeks before enrollment
  • Receiving benzodiazepines, dantrolene, tizanidine, anticoagulant, or antiepileptic medication
  • Botulinum toxin injection to the upper limb muscles within six months before enrollment
  • Severe joint contractures in the affected hand and arm
  • History of spontaneous seizure that had occurred one month or longer after the stroke

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Crossover opgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Activity Based Rehabilitation

Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice. The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance. Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session. Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Exercise therapy targeting paralyzed hand and arm

Eksperimentel: Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation

Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck. Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency. Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions. Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Exercise therapy targeting paralyzed hand and arm

Electrical stimulation of the spinal cord using surface electrodes

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from baseline - Fugl-Meyer assessment of the upper limb
Tidsramme: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

The clinician-administered a stroke-specific, performance-based impairment scale. It assesses movement function, sensation, joint range of motion, and pain. The score ranges from 0 to 66. Higher scores indicate better outcomes.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Pinch and grip force
Tidsramme: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Measurement of hand strengths using a dynamometry.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Modified Ashworth Scale
Tidsramme: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Clinician-administered test for resistance of a joint to passive movement. This scale grades muscle tone/spasticity. The score ranges from 0 to 4. Higher scores indicate worse outcomes.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Wolf Motor Function Test
Tidsramme: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Quantifies upper limb motor ability through timed and functional tasks. The score range is 0-75; higher scores denote better function.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from baseline - Action Research Arm Test
Tidsramme: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Clinician-administered observational measure to assess upper extremity performance, such as coordination, dexterity, and functioning, in stroke recovery.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Box and Blocks Test
Tidsramme: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Participants move, one by one, the maximum number of blocks from one compartment of a box to another of equal size within 60 seconds. Measures gross manual dexterity.

"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Change from baseline - Revised Nottingham Sensory Assessment
Tidsramme: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A standardized scale for assessing sensory impairment in stroke patients. Tactile sensation, proprioception, stereognosis, and two-point discrimination are evaluated.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Stroke Impact Scale
Tidsramme: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report questionnaire that evaluates disability and health-related quality of life after stroke. The questionnaire consists of 8 domains: strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function. The score ranges from 0 to 100. Higher scores indicate better outcomes.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Short Form-36
Tidsramme: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report health survey questionnaire. The score range from 0 to 100. The higher the score, the better the outcome.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Patients Global Impression of Change
Tidsramme: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

A self-report measure that reflects the participant's belief about the efficacy of treatment: the participant chooses the level of improvement and their functional status between much worse, worse, no change, improved and much improved, compared to the baseline.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - H-reflex test
Tidsramme: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of the reflex response triggered on the motor nerves when sensory fibers in the peripheral nerve are stimulated.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Somatosensory evoked potentials test
Tidsramme: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of sensory pathways between the brain and the limb.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
Change from baseline - Spinally evoked motor potentials test
Tidsramme: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Electrophysiologic evaluation of motor pathways between the central nervous system and the muscles.

"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Chet Moritz, PhD, University of Washington

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. oktober 2022

Primær færdiggørelse (Anslået)

31. december 2027

Studieafslutning (Anslået)

31. december 2027

Datoer for studieregistrering

Først indsendt

13. oktober 2022

Først indsendt, der opfyldte QC-kriterier

18. oktober 2022

Først opslået (Faktiske)

24. oktober 2022

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

4. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. oktober 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ja

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner